Open access
Open access
Powered by Google Translator Translator

Pharmacology/Pharmaceutical Industry

Lamotrigine May Increase Risk for Heart Arrhythmias, FDA Warns

5 Apr, 2021 | 01:12h | UTC

Lamotrigine May Increase Risk for Heart Arrhythmias, FDA Warns – NEJM Journal Watch

FDA Safety Communication: Lamictal (lamotrigine): Drug Safety Communication – Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease

Related commentary: Epileptologists Push Back on FDA’s New Cardiac Warning for Lamotrigine – Neurology Today

 


Recent progress in the treatment of cancer in children

5 Apr, 2021 | 01:15h | UTC

Recent progress in the treatment of cancer in children – CA: A Cancer Journal for Clinicians

 


Cohort Study: DOACs Safe, Effective in Subset of Valvular AF Patients

5 Apr, 2021 | 01:10h | UTC

DOACs Safe, Effective in Subset of Valvular AF Patients – TCTMD

Original study: Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation: A Population-Based Cohort Study – Annals of Internal Medicine

 


Cohort study: High thrombotic risk in cancer patients receiving immunotherapy

5 Apr, 2021 | 01:08h | UTC

High thrombotic risk in cancer patients receiving immunotherapy – Medical University of Vienna

Original study: Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy – Blood

 


RCT: Postoperative pain control is improved with Methadone + Ketamine vs. Methadone alone in spinal surgical patients

5 Apr, 2021 | 00:49h | UTC

Perioperative Methadone and Ketamine for Postoperative Pain Control in Spinal Surgical Patients: A Randomized, Double-blind, Placebo-controlled Trial – Anesthesiology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Exceedingly rare side effects reported with AstraZeneca vaccine in the UK – 22 cases of cerebral venous sinus thrombosis with low levels of platelets out of 18 million vaccinated individuals

5 Apr, 2021 | 01:45h | UTC

Covid-19: Seven UK blood clot deaths after AstraZeneca vaccine – BBC

Original report: Coronavirus vaccine – weekly summary of Yellow Card reporting – Medicines and Healthcare products Regulatory Agency

Related opinion: Undermining the AstraZeneca jab is a dangerous act of political folly – The Guardian

“Based on current experience, the expected benefits of both COVID-19 vaccines in preventing COVID-19 and its serious complications far outweigh any known side effects”

 


Opinion | How to lose friends and alienate people? On the problems of vaccine passports

5 Apr, 2021 | 01:42h | UTC

How to lose friends and alienate people? On the problems of vaccine passports – The BMJ Opinion

Related: Resistance from health experts and business owners could doom ‘vaccine passports’ even before they launch – STAT AND How Vaccine Passports Will Worsen Inequities In Global Health – Microbiology AND Vaccine certificates: does the end justify the means? – The Lancet Microbe AND Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND “Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine AND Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers – World Health Organization

 

Commentary on Twitter

 


Many hospitalized Covid-19 patients are given antibiotics. That’s a problem

5 Apr, 2021 | 01:33h | UTC

Many hospitalized Covid-19 patients are given antibiotics. That’s a problem – STAT

 


What we know so far about the effort to vaccinate children

5 Apr, 2021 | 01:31h | UTC

What we know so far about the effort to vaccinate children – National Geographic

 


RCT: Upadacitinib vs. Adalimumab for Psoriatic Arthritis

5 Apr, 2021 | 00:57h | UTC

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)

 


Randomized controlled trial compared three antiretroviral regimens started in pregnant women with HIV

2 Apr, 2021 | 09:15h | UTC

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)

Commentary: ART in pregnant women living with HIV – The Lancet

 


Video: Why you can’t compare Covid-19 vaccines

2 Apr, 2021 | 09:33h | UTC

Why you can’t compare Covid-19 vaccines – Vox

 


Why is it so hard to investigate the rare side effects of COVID vaccines?

2 Apr, 2021 | 09:28h | UTC

Why is it so hard to investigate the rare side effects of COVID vaccines? – Nature

 


[Press release – not published yet] Pfizer/BioNTech vaccine is 91% effective for at least 6 months

2 Apr, 2021 | 09:29h | UTC

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

Commentaries: Ongoing trial shows Pfizer Covid-19 vaccine remains highly effective after six months – CNN AND Coronavirus: Pfizer jab ‘stopping 91% of cases in first six months’ – BBC AND Expert reaction to press release from Pfizer and BioNTech on efficacy and safety up to six months after second vaccine dose, including data from South Africa – Science Media Centre AND Pfizer’s COVID-19 vaccine effective after 6 months and works against problem variant – LiveScience

 


Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19

2 Apr, 2021 | 09:36h | UTC

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 – Nature Medicine

Commentary: If I’ve Had COVID-19, Do I Still Need Two Doses of Vaccine? – TIME AND The research is in: People who’ve already had COVID-19 need just one shot – Insider

Related: Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection (studies and commentary) AND Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 – JAMA AND Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine – New England Journal of Medicine

 


Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

1 Apr, 2021 | 04:02h | UTC

Summary and Infographic: Drug treatments for covid-19: living systematic review and network meta-analysis – The BMJ

Original guideline: Therapeutics and COVID-19: living guideline – World Health Organization

News release: WHO advises that ivermectin only be used to treat COVID-19 within clinical trials – World Health Organization

Commentary: WHO joins Europe, Merck in recommending against ivermectin for COVID-19 – Reuters

 

Commentary on Twitter

https://twitter.com/ThomasAgoritsas/status/1377372928451301384

 


M-A: Vitamin D supplementation to prevent acute respiratory infections

1 Apr, 2021 | 03:30h | UTC

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials – The Lancet Diabetes & Endocrinology

Commentaries: Vitamin D to prevent acute respiratory infections – The Lancet Diabetes & Endocrinology AND

 


WHO: Sinopharm, Sinovac COVID-19 vaccine data show efficacy

1 Apr, 2021 | 03:58h | UTC

Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO – Reuters

 

Commentary on Twitter

https://twitter.com/hildabast/status/1377377034180038659

 


AstraZeneca COVID vaccine 70% effective vs. B117 variant

1 Apr, 2021 | 03:55h | UTC

AstraZeneca COVID vaccine 70% effective vs B117 variant – CIDRAP

Original study: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – The Lancet

 

Commentary on Twitter (thread – Click for more)

 


[Press release – not published yet] Pfizer-BioNTech vaccine 100% effective against Covid-19 in adolescents

1 Apr, 2021 | 03:52h | UTC

Press release: Pfizer-BioNTech Announce Positive Topline Results Of Pivotal Covid-19 Vaccine Study In Adolescents

Commentaries: The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents – The New York Times AND Covid: Children ‘well protected by Pfizer vaccine’ – BBC AND Pfizer Says COVID-19 Vaccine Shows ‘100% Efficacy’ In Adolescents – NPR AND Pfizer says its COVID-19 vaccine protects younger teens – Associated Press AND Pfizer and BioNTech say vaccine prevents Covid-19 in adolescents – STAT

 

Commentaries on Twitter

https://twitter.com/hildabast/status/1377376427239075840

 


M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

31 Mar, 2021 | 03:11h | UTC

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials – European Heart Journal (link to abstract – $ for full-text)

 


Clinical Review: Immunotherapy Management in Special Cancer Patient Populations

31 Mar, 2021 | 02:59h | UTC

Immunotherapy Management in Special Cancer Patient Populations – JCO Oncology Practice

 


[Preprint] Single dose of AstraZeneca and Pfizer vaccines shows 62% efficacy for preventing disease and reduces viral load/transmissibility of SARS-CoV-2 in residents of Long-Term Care Facilities

31 Mar, 2021 | 03:38h | UTC

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study) – medRxiv

Commentaries: Single dose of Pfizer and Oxford vaccines shows 60% efficacy in elderly care home residents – NewsMedical AND Care home residents gain 62% protection from single dose of COVID-19 vaccine – University College London

 

Commentary on Twitter (thread – click for more)

https://twitter.com/sailorrooscout/status/1376512132318121990

 


What it will take to vaccinate the world against COVID-19

31 Mar, 2021 | 03:32h | UTC

What it will take to vaccinate the world against COVID-19 – Nature

 


Opinion | Covid-19 vaccine passports will harm sustainable development

31 Mar, 2021 | 03:31h | UTC

Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion

“Where you are born can predict how freely you will be able to travel for opportunity, education, and leisure. Being a citizen of certain countries grants people access to nearly the entire globe, whereas others face challenges just to legally leave the  borders of the country they live in”

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.